Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic

European Journal of Clinical Pharmacology

Volumn 62, Issue 12, 2006, Pages 1075-1081

  Mannheimer, Buster ^a   Ulfvarson, Johanna ^a,b   Eklöf, Sara ^a   Bergqvist, Monica ^a   Andersén Karlsson, Eva ^a   Pettersson, Hans ^a   Von Bahr, Christer ^a,b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adverse drug reactions; Drug interactions; Drug utilisation; Drug related problems; Pharmacotherapeutic medication review

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; CALCIUM ANTAGONIST; DEXTROPROPOXYPHENE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; KETOBEMIDONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ZOLPIDEM;

AGED; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; COMPUTER SYSTEM; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; EDEMA; ELECTROLYTE DISTURBANCE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HOSPITAL; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICATION ERROR; MUSCLE HYPOTONIA; NEPHROTOXICITY; NURSE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEDATION; SYMPTOM; SYNCOPE;

AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; CARDIOVASCULAR DISEASES; CONSULTANTS; COST SAVINGS; COUNSELING; CREATININE; DRUG INTERACTIONS; DRUG THERAPY; DRUG UTILIZATION REVIEW; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIA; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT READMISSION; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 33751236783     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0214-z     Document Type: Article

References (25)

1. Phillips DP, Christenfeld N, Glynn LM (1998) Increase in US medication-error deaths between 1983 and 1993. Lancet 351:643-644
2. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalised patients: a meta-analysis of prospective studies. JAMA 279:1200-1205
3. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL (1997) The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 277:307-311
4. Ernst FR, Grizzle AJ (2001) Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 41:192-199
5. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N (1990) Drug-related admissions to a cardiology department; frequence and avoidability. J Intern Med 228:379-384
6. Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27:832-840
7. Roughead EE, Gilbert AL, Primrose JG, Sansom LN (1998) Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 168:405-408
8. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm B-E, Wahlin A, Dahlqvist R (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemol Drug Saf 11:65-72
9. von Laue NC, Schwappach DL, Koeck CM (2003) The epidemiology of preventable adverse drug events: a review of the literature. Wien Klin Wochenschr 115:407-415
10. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329:15-19
11. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawters AG, Newhouse JP, Weiler PC, Hiatt HH (1991) Incidence of adverse events and negligence in hospitalised patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324:370-376
12. Bates DW, Leape LL, Petrycki S (1993) Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 8:289-294
13. Thomas EJ, Studdert DM, Burstin HR, Orav EJ, Zeena T, Williams EJ, Howard KM, Weiler PC, Brennan TA (2000) Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 38:261-271
14. Pharmaceutical Care Network Europe (2003) DRP-classification V4.0. http://www.pcne.org/dokumenter/PCNE%20scheme%20V400.htm. Cited 26 May 2003
15. Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK (2004) The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 60:651-658
16. Midlov P, Bondesson A, Eriksson T, Petersson J, Minthon L, Hoglund P (2002) Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden. Eur J Clin Pharmacol 57:903-910
17. Ulfvarson J, Adami J, Ullman B, Wredling R, Reilly M, von Bahr C (2003) Randomised controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiol Drug Saf 12:589-593
18. Stewart S, Pearson S, Luke CG, Horowitz JD (1998) Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 46:174-180
19. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ (2001) Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 323:1340-1343
20. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G, Seymour DG (2001) Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 30:205-211
21. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H (2001) A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing 30:33-40
22. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, Christou M, Evans D, Hand C (2005) Does home-based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 330:293
23. Läkemedelsindustriföreningen LIF (2003) Interactions. http://drugdb.janusinfo.se/ddb/interactions/. Cited between 15 October 2003 and 14 July 2004
24. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
25. World Health Organization (1972) International drug monitoring: the role of national centres. WHO Technical Report 498. World Heath Organisation, Geneva